Therapeutics Market Research Reports

Titlepublishedprice

Eculizumab – Comprehensive patent search

By Ark Patent Intelligence
"......ighly trained, qualified staff using proprietary searching techniques, you won’t need to worry about missing patents or updating data. And that means your IP staff will be freed up to concentrate on your business, rather than getting bogged down in......"
16-Sep-2014$9300

Elvitegravir – Comprehensive patent search

By Ark Patent Intelligence
"......ighly trained, qualified staff using proprietary searching techniques, you won’t need to worry about missing patents or updating data. And that means your IP staff will be freed up to concentrate on your business, rather than getting bogged down in......"
16-Sep-2014$7500

Mirabegron – Comprehensive patent search

By Ark Patent Intelligence
"......ighly trained, qualified staff using proprietary searching techniques, you won’t need to worry about missing patents or updating data. And that means your IP staff will be freed up to concentrate on your business, rather than getting bogged down in......"
16-Sep-2014$6201

Elvitegravir – Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

By Ark Patent Intelligence
"......he-know. "The most extensive source of patent information available." Product Portfolio Manager - Dr Reddys Laboratories "The database is reliable, frequently updated, well-arranged, user friendly." Director IP - Zentiva k.s "Allows me to pe......"
16-Sep-2014$1400

OpportunityAnalyzer: Allergic Conjunctivitis – Opportunity Analysis and Forecasts to 2018

By GlobalData
"......eformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth. By 2023, the migraine market will grow to $3.7 billion at a compound annual grow......"
15-Sep-2014$5995

Epicast Report: Diabetic Macular Edema – Epidemiology Forecast to 2023

By GlobalData
"......ME is highly frequent in diabetics and usually manifests itself as diabetic macular edema (DME). DME is often a complication of diabetic retinopathy, and is the most common cause of vision loss in individuals with diabetes, especially if left untreat......"
10-Sep-2014$3995

EpiCast Report: Breast Cancer (HER2-, HER2+) – Epidemiology Forecast to 2023

By GlobalData
"......s and exogenous sex hormones, gene mutations, a family history of breast cancer, overweight and obesity, physical inactivity, a sedentary lifestyle, high alcohol consumption, early age at menarche (<12 years), late age at menopause (>55 years),......"
10-Sep-2014$3995

EpiCast Report: Age-Related Macular Degeneration – Epidemiology Forecast to 2023

By GlobalData
"......In addition to the high prevalence of the condition, AMD is associated with severe disability and has a major impact on the quality of life and emotional well-being of an affected individual. AMD is classified into two stages: early AMD and late AMD......."
10-Sep-2014$3995

Chronic Cough – Pipeline Review, H2 2014

By Global Markets Direct
"......omparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players in......"
10-Sep-2014$2000

Errant Gene Therapeutics, LLC – Product Pipeline Review – 2014

By Global Markets Direct
"......hensive information on the current therapeutic developmental pipeline of Errant Gene Therapeutics, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration......"
10-Sep-2014$1500
Live Chat
Live Chat by Comm100